We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Groupon (GRPN) to Report Q4 Earnings: What's in the Offing?
Read MoreHide Full Article
Groupon, Inc. (GRPN - Free Report) is scheduled to report fourth-quarter 2020 results on Feb 25.
The Zacks Consensus Estimate for loss per share has been steady at loss of 18 cents in the past 30 days. In the fourth quarter of 2019, Groupon had reported non-GAAP earnings per share of 7 cents.
The Zacks Consensus Estimate for fourth-quarter revenues is pegged at $281.8 million, which indicates a decline of 54% from the year-ago quarter’s reported figure.
Notably, the company’s earnings surpassed the Zacks Consensus Estimate in three of the trailing four quarters, while missing in the remaining quarter. It has a trailing four-quarter earnings surprise of 38.4%, on average.
Q3 at a Glance
In third-quarter 2020, the company generated revenues of $304 million, down 38.7% from the year-ago quarter’s reported figure and 23.2% sequentially.
Non-GAAP earnings per share during the quarter were 15 cents compared with non-GAAP earnings of 27 cents per share reported in the year-ago quarter and non-GAAP loss per share of 93 cents reported in the previous quarter.
Let’s see how things have shaped up prior to this announcement.
Factors to Note
Groupon’s fourth-quarter revenues are likely to reflect the negative impact of the ongoing pandemic on restaurants and travel bookings. Further, these sectors are likely to have been hit hard due to the re-imposition of shelter-in-place guidelines across several countries.
Further, higher investments on platform enhancement amid intense competition in the e-commerce space are also anticipated to have put pressure on fourth-quarter EBITDA.
Nonetheless, Groupon’s fourth-quarter performance is expected to have been cushioned by restructuring efforts as well as its continuing pivot strategy.
The company has adopted an ambitious cost-containment strategy. In third quarter of 2020, Groupon began its second phase of the restructuring initiative. Fourth-quarter margins are anticipated to have benefitted from restructuring efforts.
As a part of its pivot strategy, Groupon has been expanding inventory to boost billings growth and improve purchase frequency.
Moreover, the company is reducing restrictions on its deeply-discounted deals and enabling customers to purchase such deals many times.
The daily deals provider is also working on improving its merchant and customer experiences to drive growth. The company is also focusing on local experiences marketplace as this market presents significant revenue growth opportunity. Initiatives to improve quality and all-time-available inventory is likely to have attracted more consumers to its platform.
In the third quarter of 2020, Groupon rolled out sponsored listings tool to assist merchants in expanding consumer reach. Also, it unveiled Google two-way calendar sync that will facilitate merchants to manage booking leveraging the Google Calendar.
Groupon has been adding new features to its platform like map-based search feature, along with optimizing relevance and search results to enhance customer experience.
These initiatives are likely to have contributed to the top line in the to-be-reported quarter.
Key Developments in Q4
In November 2020, Groupon teamed up with digital travel booking and reservation platform, Xola for its Groupon Connect platform. The collaboration will facilitate merchants on Xola’s platform to link their Xola bookings to the Groupon promotions.
What the Zacks Model Unveils
Our proven model does not predict an earnings beat for Groupon this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here.
Groupon has an Earnings ESP of 0.00% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Workday (WDAY - Free Report) has an Earnings ESP of +1.21% and currently carries a Zacks Rank of 2.
Autodesk (ADSK - Free Report) has an Earnings ESP of +2.29% and carries a Zacks Rank of 2, at present.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Groupon (GRPN) to Report Q4 Earnings: What's in the Offing?
Groupon, Inc. (GRPN - Free Report) is scheduled to report fourth-quarter 2020 results on Feb 25.
The Zacks Consensus Estimate for loss per share has been steady at loss of 18 cents in the past 30 days. In the fourth quarter of 2019, Groupon had reported non-GAAP earnings per share of 7 cents.
The Zacks Consensus Estimate for fourth-quarter revenues is pegged at $281.8 million, which indicates a decline of 54% from the year-ago quarter’s reported figure.
Groupon, Inc. Price and EPS Surprise
Groupon, Inc. price-eps-surprise | Groupon, Inc. Quote
Notably, the company’s earnings surpassed the Zacks Consensus Estimate in three of the trailing four quarters, while missing in the remaining quarter. It has a trailing four-quarter earnings surprise of 38.4%, on average.
Q3 at a Glance
In third-quarter 2020, the company generated revenues of $304 million, down 38.7% from the year-ago quarter’s reported figure and 23.2% sequentially.
Non-GAAP earnings per share during the quarter were 15 cents compared with non-GAAP earnings of 27 cents per share reported in the year-ago quarter and non-GAAP loss per share of 93 cents reported in the previous quarter.
Let’s see how things have shaped up prior to this announcement.
Factors to Note
Groupon’s fourth-quarter revenues are likely to reflect the negative impact of the ongoing pandemic on restaurants and travel bookings. Further, these sectors are likely to have been hit hard due to the re-imposition of shelter-in-place guidelines across several countries.
Further, higher investments on platform enhancement amid intense competition in the e-commerce space are also anticipated to have put pressure on fourth-quarter EBITDA.
Nonetheless, Groupon’s fourth-quarter performance is expected to have been cushioned by restructuring efforts as well as its continuing pivot strategy.
The company has adopted an ambitious cost-containment strategy. In third quarter of 2020, Groupon began its second phase of the restructuring initiative. Fourth-quarter margins are anticipated to have benefitted from restructuring efforts.
As a part of its pivot strategy, Groupon has been expanding inventory to boost billings growth and improve purchase frequency.
Moreover, the company is reducing restrictions on its deeply-discounted deals and enabling customers to purchase such deals many times.
The daily deals provider is also working on improving its merchant and customer experiences to drive growth. The company is also focusing on local experiences marketplace as this market presents significant revenue growth opportunity. Initiatives to improve quality and all-time-available inventory is likely to have attracted more consumers to its platform.
In the third quarter of 2020, Groupon rolled out sponsored listings tool to assist merchants in expanding consumer reach. Also, it unveiled Google two-way calendar sync that will facilitate merchants to manage booking leveraging the Google Calendar.
Groupon has been adding new features to its platform like map-based search feature, along with optimizing relevance and search results to enhance customer experience.
These initiatives are likely to have contributed to the top line in the to-be-reported quarter.
Key Developments in Q4
In November 2020, Groupon teamed up with digital travel booking and reservation platform, Xola for its Groupon Connect platform. The collaboration will facilitate merchants on Xola’s platform to link their Xola bookings to the Groupon promotions.
What the Zacks Model Unveils
Our proven model does not predict an earnings beat for Groupon this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here.
Groupon has an Earnings ESP of 0.00% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks That Warrant a Look
CrowdStrike. (CRWD - Free Report) has an Earnings ESP of +13.92% and carries a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Workday (WDAY - Free Report) has an Earnings ESP of +1.21% and currently carries a Zacks Rank of 2.
Autodesk (ADSK - Free Report) has an Earnings ESP of +2.29% and carries a Zacks Rank of 2, at present.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>